Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 2,413-2,424 of 4,306
Drug study icon
CompletedNCT00575666

Intranasal Insulin Treatment in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Worcester
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States
Sponsor
University of Massachusetts, Worcester
Condition
Schizophrenia
Drug study icon
CompletedNCT00088075

Investigate Risperidone for Schizophrenia in Adolescents

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 13 Years to 17 Years
Countries
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Schizophrenia
Other study type icon
UnknownNCT06782672

Investigation of Objective Cognitive Effort in Neuropsychological Evaluation of Psychotic Disorders

This summary needs review. Please check the official study record and contact the research team for details.

In Montpellier
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalA study where researchers collect information without assigning a treatment.From 18 Years to 60 Years
Countries
France
Sponsor
University Hospital, Montpellier
Condition
Schizophrenia
Other study type icon
TerminatedNCT03209778

Involuntary Memories Investigation in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Strasbourg
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
France
Sponsor
University Hospital, Strasbourg, France
Condition
Schizophrenia
Drug study icon
TerminatedNCT03817528

ITI-007 (Lumateperone Tosylate) for Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In New York
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 60 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
Schizophrenia
Other study type icon
CompletedNCT00686101

Knowledge and Perception of Smoking Risks/Consequences

This summary needs review. Please check the official study record and contact the research team for details.

In Baltimore
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
Drug study icon
CompletedNCT00718510

L-arginine in Treatment as Usual in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Edmonton
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
Canada
Sponsor
University of Alberta
Condition
Schizophrenia
Other study type icon
CompletedNCT00372151

L-Theanine in the Management of Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Beersheba
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
Israel
Sponsor
Sha'ar Menashe Mental Health Center
Condition
Schizophrenia
Drug study icon
TerminatedNCT00947375

Lamictal TM, Haloperidol Decanoate in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Baku
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 60 Years
Countries
Azerbaijan
Sponsor
Central Mental Clinic for Outpatients of Baku City
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.